Anchiano Therapeutics Ltd. Contracts & Agreements
24 Contracts & Agreements
- Business Finance (14 contracts)
- Business Operations (1)
- Human Resources (7)
- Mergers & Acquisitions (1)
- Uncategorized (1)
- Form of Underwriting Agreement (Filed With SEC on March 21, 2023)
- Form of Warrant (Filed With SEC on March 21, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on March 21, 2023)
- Form of Underwriting Agreement (Filed With SEC on February 21, 2023)
- Form of Warrant (Filed With SEC on February 21, 2023)
- Form of Deposit Agreement between Chemomab Therapeutics Ltd. (f/k/a Anchiano Therapeutics Ltd.), the Bank of New York Mellon as Depositary, and owners and holders from time to... (Filed With SEC on January 13, 2023)
- Employment Agreement, dated September 1, 2021, by and between Chemomab Therapeutics, Inc. and Dale Pfost (Filed With SEC on January 13, 2023)
- Employment Agreement, dated November 8, 2021, by and between Chemomab Therapeutics, Inc. and Donald Marvin (Filed With SEC on January 13, 2023)
- Consulting Agreement, dated April 18, 2022, by and between Chemomab Ltd. and Dr. Adi Mor (Filed With SEC on January 13, 2023)
- Employment Agreement, dated October 10, 2022, by and between Chemomab Therapeutics, Inc. and Matthew B. Frankel (Filed With SEC on November 29, 2022)
- Description of Share Capital (Filed With SEC on March 30, 2022)
- Compensation Policy for Officers and Directors (Filed With SEC on March 30, 2022)
- Employment Agreement, dated September 1, 2021, by and between Chemomab Therapeutics, Inc. and Dale Pfost (Filed With SEC on March 30, 2022)
- Employment Agreement, dated November 8, 2021, by and between Chemomab Therapeutics, Inc. and Donald Marvin (Filed With SEC on March 30, 2022)
- Form of Securities Purchase Agreement, dated March 15, 2021, by and between Chemomab Therapeutics Ltd. (formerly known as Anchiano Therapeutics Ltd.) and certain purchasers (Filed With SEC on March 17, 2021)
- Form of American Depositary Shares Purchase Warrant of Chemomab Therapeutics Ltd (Filed With SEC on March 17, 2021)
- Form of Anti-Dilution Warrant of Chemomab Therapeutics Ltd. (formerly known as Anchiano Therapeutics Ltd.) (Filed With SEC on March 17, 2021)
- Asset Purchase and Assignment Agreement, dated as of March 16, 2021, made between Anchiano Therapeutics, Inc. and Kestrel Therapeutics, Inc (Filed With SEC on March 17, 2021)
- Agreement and Plan of Merger, dated December 14, 2020, by and among Anchiano Therapeutics Ltd., Chemomab Ltd. and CMB Acquisition Ltd (Filed With SEC on December 15, 2020)
- Form of Company Shareholder Support Agreement, dated December 14, 2020, by and between Chemomab Ltd. and each of the parties named in each agreement thereof (Filed With SEC on December 15, 2020)
- Form of Chemomab Shareholder Support Agreement, dated December 14, 2020, by and between Anchiano Therapeutics Ltd. and each of the parties named in each agreement thereof (Filed With SEC on December 15, 2020)
- Form of Lock-Up Agreement, dated December 14, 2020, by each of the parties named in each agreement thereof (Filed With SEC on December 15, 2020)
- Chemomab Warrant, dated December 14, 2020, by and among Anchiano Therapeutics Ltd. and the shareholders of Chemomab (Filed With SEC on December 15, 2020)
- Cashless Exercise Notice, Amendment, Waiver, Release and Termination, dated December 14, 2020, by and among Anchiano Therapeutics Ltd., Shavit Capital Fund III (US), L.P., Shavit... (Filed With SEC on December 15, 2020)
